Trials / Completed
CompletedNCT01237288
Therapeutic Use of Oral Sodium Phosphate (Z-521) in Primary Hypophosphatemic Rickets
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Zeria Pharmaceutical · Industry
- Sex
- All
- Age
- 1 Year – 14 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the efficacy and safety of oral phosphate (Z-521) in subjects with primary hypophosphatemic rickets.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Z-521 |
Timeline
- Start date
- 2010-09-01
- Primary completion
- 2013-04-01
- Completion
- 2013-07-01
- First posted
- 2010-11-09
- Last updated
- 2013-10-01
Locations
4 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT01237288. Inclusion in this directory is not an endorsement.